WSJ’s MarketWatch interviews the CEO of Clinical Data, Drew Fromkin. They talk about his ideas on biomarkers, GINA, personalized medicine, and what it means for consumers whose confidence in genetic testing, and the insurance coverage they may or may not get, is just starting to improve.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.